METROPOLITAN LIFE INSURANCE CO/NY - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$69,781
-62.5%
8,347
+11.4%
0.00%
-55.6%
Q2 2023$186,151
+71.7%
7,494
+4.0%
0.01%
+50.0%
Q1 2023$108,408
+14.1%
7,208
-10.2%
0.01%
+50.0%
Q4 2022$94,983
+99.8%
8,0290.0%0.00%
+100.0%
Q3 2022$47,532
+79.3%
8,029
+28.7%
0.00%
+100.0%
Q2 2022$26,516
-67.7%
6,239
-27.7%
0.00%
-66.7%
Q1 2022$82,033
-87.7%
8,626
-75.4%
0.00%
-66.7%
Q4 2021$666,311
-42.9%
35,0690.0%0.01%
-47.1%
Q3 2021$1,167,096
-13.1%
35,069
+1.3%
0.02%
-10.5%
Q2 2021$1,343,530
-14.0%
34,636
+6.8%
0.02%
-17.4%
Q1 2021$1,562,740
-6.6%
32,422
+0.8%
0.02%
-8.0%
Q4 2020$1,673,587
+94.4%
32,1720.0%0.02%
+66.7%
Q3 2020$860,923
+48.9%
32,172
+8.4%
0.02%
+50.0%
Q2 2020$578,303
+112.1%
29,687
+7.2%
0.01%
+66.7%
Q1 2020$272,598
-4.9%
27,703
+7.2%
0.01%
+20.0%
Q4 2019$286,791
+87.2%
25,837
-5.3%
0.01%
+66.7%
Q3 2019$153,228
-17.8%
27,289
+26.6%
0.00%0.0%
Q2 2019$186,415
+30.4%
21,551
+21.2%
0.00%0.0%
Q1 2019$142,959
+74.6%
17,781
-11.0%
0.00%
+50.0%
Q4 2018$81,893
-26.8%
19,9740.0%0.00%0.0%
Q3 2018$111,854
-100.0%
19,9740.0%0.00%
-50.0%
Q2 2018$262,658,000
+13.1%
19,974
+22.1%
0.00%
+33.3%
Q1 2018$232,284,000
+173246.3%
16,3580.0%0.00%
+50.0%
Q4 2017$134,000
-62.6%
16,358
-45.9%
0.00%0.0%
Q3 2017$358,000
+17.8%
30,2470.0%0.00%0.0%
Q2 2017$304,000
-13.6%
30,2470.0%0.00%0.0%
Q1 2017$352,000
+72.5%
30,247
+14.7%
0.00%
+100.0%
Q3 2016$204,000
+32.5%
26,377
+3.7%
0.00%0.0%
Q2 2016$154,000
-29.0%
25,4320.0%0.00%
-50.0%
Q1 2016$217,000
-28.4%
25,4320.0%0.00%0.0%
Q4 2015$303,000
+18.4%
25,4320.0%0.00%0.0%
Q3 2015$256,000
-39.3%
25,4320.0%0.00%
-33.3%
Q2 2015$422,000
+40.2%
25,432
+30.8%
0.00%
+50.0%
Q1 2015$301,000
-2.3%
19,4480.0%0.00%0.0%
Q4 2014$308,000
+48.1%
19,4480.0%0.00%
+100.0%
Q3 2014$208,000
+13.7%
19,4480.0%0.00%0.0%
Q2 2014$183,00019,4480.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BRIDGER MANAGEMENT, LLC 1,647,000$6,423,0000.45%
DAFNA Capital Management LLC 75,000$293,0000.30%
Baker Brothers Advisors 2,199,656$8,579,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 71,105$277,0000.05%
SMITH ASSET MANAGEMENT GROUP LP 196,684$767,0000.03%
SABBY MANAGEMENT, LLC 66,000$257,0000.02%
THOMPSON DAVIS & CO., INC. 1,000$4,0000.01%
COLUMBUS CIRCLE INVESTORS 161,919$631,0000.00%
JENNISON ASSOCIATES LLC 455,271$1,776,0000.00%
BlackRock Fund Advisors 448,445$1,749,0000.00%
View complete list of TG THERAPEUTICS INC shareholders